Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Biliary Tract Diseases

Free Subscription 03.06.2024 1 BMC Surg 2 Endoscopy 1 Gastroenterology 1 J Gastroenterol Hepatol 1 J Hepatol 4 N Engl J Med 3 Surg Endosc 2 Surgery

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Surg

1. ZHU Y, Li J, Gao J, Bai D, et al
   Effect of simethicone for the management of early abdominal distension after laparoscopic cholecystectomy: a multicenter retrospective propensity score matching study.
   BMC Surg. 2024;24:170.
   PubMed         Abstract available
   
   

   
   Endoscopy

2. NODA J, Takano Y, Yamawaki M, Azami T, et al
   Endoscopic transpapillary gallbladder drainage using a novel drill dilator.
   Endoscopy. 2024;56.
   PubMed        
   
   
3. RIZZO GEM, Carrozza L, Gruttadauria S, Bertani A, et al
   A swirl ERCP during combined endoscopic-radiological-surgical management of a late-onset post-traumatic obstructive jaundice.
   Endoscopy. 2024;56.
   PubMed        
   
   

   
   Gastroenterology

4. WANG R, Li B, Huang B, Li Y, et al
   Gut microbiota-derived butyrate induces epigenetic and metabolic reprogramming in myeloid-derived suppressor cells to alleviate primary biliary cholangitis.
   Gastroenterology. 2024 May 27:S0016-5085(24)04936.
   PubMed         Abstract available
   
   

   
   J Gastroenterol Hepatol

5. HAYASHI M, Abe K, Sugaya T, Takahata Y, et al
   A low baseline serum myostatin concentration is associated with poor clinical outcome in patients with primary biliary cholangitis.
   J Gastroenterol Hepatol. 2024 May 30. doi: 10.1111/jgh.16639.
   PubMed         Abstract available
   
   

   
   J Hepatol

6. REVIEJO M, Lozano E, Marin JJG
   Impact of alternative splicing on cholangiocarcinoma progression through metabolic rewiring-induced epigenetic events.
   J Hepatol. 2024 May 27:S0168-8278(24)00365-9. doi: 10.1016/j.jhep.2024.
   PubMed        
   
   

   
   N Engl J Med

7. KOWDLEY KV, Levy C, Jones D
   Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
   N Engl J Med. 2024;390:1935-1936.
   PubMed        
   
   
8. HIRSCHFIELD GM, Kremer AE, Levy C
   Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis. Reply.
   N Engl J Med. 2024;390:1934-1935.
   PubMed        
   
   
9. IJICHI H
   Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
   N Engl J Med. 2024;390:1934.
   PubMed        
   
   
10. AREVALO-CANAS C, Arevalo-Serrano J
    Phase 3 Trials of Elafibranor and Seladelpar for Primary Biliary Cholangitis.
    N Engl J Med. 2024;390:1933-1934.
    PubMed        
    
    

    
    Surg Endosc

11. YANG W, Peng Y, Yang Y, Liang B, et al
    Caudo-dorsal approach combined with the occlusion of right hepatic vein and Pringle maneuver in laparoscopic anatomical resection of segment 7.
    Surg Endosc. 2024;38:3455-3460.
    PubMed         Abstract available
    
    
12. KUMAR SS, Collings AT, Wunker C, Athanasiadis DI, et al
    SAGES guidelines for the use of laparoscopy during pregnancy.
    Surg Endosc. 2024;38:2947-2963.
    PubMed         Abstract available
    
    
13. GLOOR S, Minder S, Schnell B, Prevost GA, et al
    Antegrade balloon dilatation of the duodenal papilla during laparoscopic cholecystectomy versus endoscopic retrograde cholangiography in patients with acute choledocholithiasis: a case control matched study.
    Surg Endosc. 2024 May 29. doi: 10.1007/s00464-024-10909.
    PubMed         Abstract available
    
    

    
    Surgery

14. COMES DJ, Thunnissen FM, Latenstein CSS, Stommel MWJ, et al
    Unraveling factors associated with textbook outcome after cholecystectomy in patients with uncomplicated cholecystolithiasis: A posthoc analysis of individual data of 1,124 patients.
    Surgery. 2024 May 29:S0039-6060(24)00274-5. doi: 10.1016/j.surg.2024.
    PubMed         Abstract available
    
    
15. MASHIKO T, Carreras J, Ogasawara T, Masuoka Y, et al
    Intrahepatic cholangiocarcinoma with arterial phase hyperenhancement and specialized tumor microenvironment associated with good prognosis after radical resection: A single-center retrospective study.
    Surgery. 2024 May 24:S0039-6060(24)00189-2. doi: 10.1016/j.surg.2024.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.